Michelle Levinson is a Hayward, California based nurse practitioner. Active license number of Michelle Levinson is 95010707 for Women Health in California. Her current practice location is 1032 A St, Hayward. Patients can reach her at 510-300-3800 or can fax her at 510-300-8039. Michelle Levinson is CNM, WHNP and her NPI number (Unique professional ID assigned by NPPES) is 1558835991. Michelle Levinson has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Michelle Levinson speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1558835991
NPI Enumeration Date:
18 Jan, 2019
NPI Last Update On:
18 Jan, 2019
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Michelle Levinson are as mentioned below.
License Number
Specialization
State
Status
95010707
Women Health
California
Primary
Midwife
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Michelle Levinson 1691 The Alameda, San Jose, California
Zip:
95126-2203
Patients can reach Michelle Levinson at 1032 A St, Hayward, California or can call to book an appointment on 510-300-3800.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.